Role of α- and β-defensins in lower respiratory tract infections Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007
The role of atypical pathogens in the respiratory failure caused by lower respiratory tract infections Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Lower respiratory tract infections: diagnosis and treatment in clinical practice Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice" Year: 2014
Fatal outcome in lower respiratory tract infections Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004
The management of severe sepsis in respiratory tract infections Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections Year: 2013
The role of respiratory viruses in the respiratory failure caused by lower respiratory tract infections Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003
Guidelines for the management of adult lower respiratory tract infections Source: Guideline 2005 Year: 2005
Guidelines for the management of adult lower respiratory tract infections Source: Eur Respir J 2005; 26: 1138-1180 Year: 2005
The role of the microbiome in the clinical management of respiratory infections Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats Year: 2016
The role of atypical pathogens in etiology of respiratory tract infection among pediatric patients in Georgia Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002
Prevalence of respiratory pathogens in children hospitalized with lower respiratory tract infection Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007
Clinical profile and risk factors in hospitalized children with lower respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 392s Year: 2007
Advances in diagnostic tools for lower respiratory tract infections Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era Year: 2021
Immunological parameters in Down syndrome children with and without recurrent lower respiratory tract infections Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021
Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections Source: Eur Respir J, 51 (3) 1701656; 10.1183/13993003.01656-2017 Year: 2018
Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Source: Eur Respir J 2011; 37: 112-118 Year: 2011
The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract infections Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
Guidelines for management of adult community-acquired lower respiratory tract infections Source: Guideline 1998 Year: 1998
The clinical evaluation of respiratory tract infection caused by MRSA Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012